News for AstraZeneca plc (ZEG.BE)

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have originated in the Amazonian city of Manaus

Canadian regulators have given the green light to Johnson & Johnson’s (NYSE:JNJ) COVID-19 vaccine.

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have originated in the Amazonian city of Manaus, said the source, who requested anonymity as the results have not yet been made public.

With vaccinations lagging, Indonesia’s government has authorized private companies to acquire Covid-19 vaccines, but some public-health experts say the strategy will steer shots toward the middle-class and wealthy.

A botched deal last year between Canada and Chinese vaccine manufacturer CanSino Biologics Inc. laid bare this country’s vulnerabilities amid efforts to devise a proper immunization plan.

The supply disruption concerns have arisen after the Biden administration announced plans to use the Defense Production Act to boost supplies needed to make Pfizer Inc.’s vaccines

JCR Pharmaceuticals Co said on Thursday it would build a new plant in Japan to expand production of ingredients for COVID-19 vaccines over the longer term. JCR Pharma along with Daiichi Sankyo Co and other Japanese partners are cooperating to produce and distribute the COVID-19 vaccine developed by AstraZeneca Plc…

The U.S. death toll from the coronavirus-borne illness COVID-19 climbed above 518,000 on Thursday, as President Joe Biden added his voice to a chorus of...

Hagens Berman urges XL Fleet Corp. (NYSE: XL) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.

NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC ...

The embattled financial startup plans to file for insolvency as it simultaneously moved toward a deal to sell its operating business to Apollo Global Management.

The president said enough vaccines would be available two months earlier than he had previously indicated, after Merck agreed to help Johnson & Johnson produce shots.

Pressure mounted on the embattled SoftBank-backed financial firm as it scrambled to sell core parts of its business and regulators intensified supervision of its banking unit.

By Sabrina Siddiqui and Tarini Parti Merck & Co. will help produce Johnson & Johnson's single-dose Covid-19 vaccine, President Biden plans to announce Tuesday, as the administration... | March 2, 2021

Covina CA, March 02, 2021 (GLOBE NEWSWIRE) -- Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ ...

The president said enough vaccines would be available two months earlier than he had previously indicated, after Merck agreed to help Johnson & Johnson produce shots.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ma...

Vancouver, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- The global immunotherapy drugs market is projected to reach value of USD 365.57 Billion by ...

New York, NY, March 01, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled "Type 1 Diabetes Market By Insulin Analog ...